69 research outputs found

    Singing teaching as a therapy for chronic respiratory disease - a randomised controlled trial and qualitative evaluation

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Despite optimal pharmacological therapy and pulmonary rehabilitation, patients with COPD continue to be breathless. There is a need to develop additional strategies to alleviate symptoms. Learning to sing requires control of breathing and posture and might have benefits that translate into daily life.</p> <p>Methods</p> <p>To test this hypothesis we performed a randomised controlled trial, comparing a six week course of twice weekly singing classes to usual care, in 28 COPD patients. The experience of singing was assessed in a qualitative fashion, through interviews with a psychologist. In addition, we surveyed patients with chronic respiratory conditions who participated in a series of open singing workshops.</p> <p>Results</p> <p>In the RCT, the physical component score of the SF36 improved in the singers (n = 15) compared to the controls (n = 13); +7.5(14.6) vs. -3.8(8.4) p = 0.02. Singers also had a significant fall in HAD anxiety score; -1.1(2.7) vs. +0.8(1.7) p = 0.03. Singing did not improve single breath counting, breath hold time or shuttle walk distance. In the qualitative element, 8 patients from the singing group were interviewed. Positive effects on physical sensation, general well-being, community/social support and achievement/efficacy emerged as common themes. 150 participants in open workshops completed a questionnaire. 96% rated the workshops as "very enjoyable" and 98% thought the workshop had taught them something about breathing in a different way. 81% of attendees felt a "marked physical difference" after the workshop.</p> <p>Conclusion</p> <p>Singing classes can improve quality of life measures and anxiety and are viewed as a very positive experience by patients with respiratory disease; no adverse consequences of participation were observed.</p> <p>Trial Registration</p> <p>Current Controlled Trials - ISRCTN17544114.</p

    Stability of insulating phase in the chiral Kondo lattice model

    Full text link
    In this work, the stability of the insulating phase of the 1D chiral Kondo lattice model is studied at half-filling, within the framework of self-consistent variational theory. It is found that arbitrarily small interaction would drive the system from a conducting phase to an insulating phase, in spite of the chirality of the conducting band.Comment: 10 pages, IPT-EPFL preprint, submitted to PRB as a brief report for publicatio

    The role of porosity in H2/He production ratios in fracture fluids from the Witwatersrand Basin, South Africa

    Get PDF
    Abiotic H2 produced in the Precambrian lithospheric crust is a key substrate at the base of the metabolic chain of chemosynthetic and photosynthesis-independent microbial communities, significant to our understanding of life on early Earth and other planets. H2 cycling processes are also relevant to recent hydrogen exploration efforts and engineered subsurface environments such as radioactive waste disposal sites. In the lithospheric crust, H2 is produced through water-rock reactions (serpentinisation) and radiolysis; the latter directly linked to He through radioelement decay (U, Th). The Witwatersrand Basin in South Africa is an ideal place to study the radiolytic production pathway in particular, because of the low abundance of ultramafic and mafic minerals and therefore low potential for serpentinisation reactions. Gas samples and gas flow rate data (n = 12) were collected from the surface of exploration boreholes tapping the Witwatersrand and Ventersdorp Supergroups. The samples were predominantly composed of CH4 (65–99%), N2 (3–27%), He (0.1–15%), and trace amounts of C2+ hydrocarbons. Notably, H2 in these samples was below detection limit, despite the presence of He - providing a critical indicator of processes removing H2 from the system. Using a Bayesian modelling approach, we test the hypothesis that the observed fluids are generated in-situ, driven by radioelement decay and subsequent microbial methanogenesis, and controlled by porosity of the host rock. The observed data is consistent with this hypothesis, and can be accounted for by a variation in porosity between 0.3 and 2.2% (typical values to Precambrian basement) across the different sampling sites. These He-rich hydrocarbon gases observed at the surface originate from a hydrogeological system that is porosity-constrained and isolated from externally-sourced fluids. Radioelement decay is the primary process driving the generation of H2 and therefore energy production in this subsurface system, utilised by hydrogenotrophic methanogens at the base of the deep carbon cycle. Microbial utilisation is the key mechanism for H2 consumptions and, conversely, preservation, suggesting that conditions favourable to commercial H2 discoveries are likely constrained to hypersaline environments where microbial activity is inhibited. The model results under the proposed hypothesis (consistent N2/H2 ratio between different boreholes) raises the possibility that N2, which often co-occurs with He-rich deep fluids, is also produced through radiolysis, and future work is needed to fully evaluate this hypothesis

    The Inherent Tracer Fingerprint of Captured CO2.

    Get PDF
    Carbon capture and storage (CCS) is the only currently available technology that can directly reduce anthropogenic CO2 emissions arising from fossil fuel combustion. Monitoring and verification of CO2 stored in geological reservoirs will be a regulatory requirement and so the development of reliable monitoring techniques is essential. The isotopic and trace gas composition - the inherent fingerprint - of captured CO2 streams is a potentially powerful, low cost geochemical technique for tracking the fate of injected gas in CCS projects; carbon and oxygen isotopes, in particular, have been used as geochemical tracers in a number of pilot CO2 storage sites, and noble gases are known to be powerful tracers of natural CO2 migration. However, the inherent tracer fingerprint in captured CO2 streams has yet to be robustly investigated and documented and key questions remain, including how consistent is the fingerprint, what controls it, and will it be retained en route to and within the storage reservoir? Here we present the first systematic measurements of the carbon and oxygen isotopes and the trace noble gas composition of anthropogenic CO2 captured from combustion power stations and fertiliser plants. The analysed CO2 is derived from coal, biomass and natural gas feedstocks, using amine capture, oxyfuel and gasification processes, from six different CO2 capture plants spanning four different countries. We find that δ13C values are primarily controlled by the δ13C of the feedstock while δ18O values are predominantly similar to atmospheric O2. Noble gases are of low concentration and exhibit relative element abundances different to expected reservoir baselines and air, with isotopic compositions that are similar to air or fractionated air. The use of inherent tracers for monitoring and verification was provisionally assessed by analysing CO2 samples produced from two field storage sites after CO2 injection. These experiments at Otway, Australia, and Aquistore, Canada, highlight the need for reliable baseline data. Noble gas data indicates noble gas stripping of the formation water and entrainment of Kr and Xe from an earlier injection experiment at Otway, and inheritance of a distinctive crustal radiogenic noble gas fingerprint at Aquistore. This fingerprint can be used to identify unplanned migration of the CO2 to the shallow subsurface or surface

    Non-invasive ventilation (NIV) as an aid to rehabilitation in acute respiratory disease

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Non-invasive ventilation (NIV) can increase exercise tolerance, reduce exercise induced desaturation and improve the outcome of pulmonary rehabilitation in patients with chronic respiratory disease. It is not known whether it can be applied to increase exercise capacity in patients admitted with non-hypercapnic acute exacerbations of COPD (AECOPD). We investigated the acceptability and feasibility of using NIV for this purpose.</p> <p>Methods</p> <p>On a single occasion, patients admitted with an acute exacerbation of chronic respiratory disease who were unable to cycle for five minutes at 20 watts attempted to cycle using NIV and their endurance time (T<sub>lim</sub>) was recorded. To determine feasibility of this approach in clinical practice patients admitted with AECOPD were screened for participation in a trial of regular NIV assisted rehabilitation during their hospital admission.</p> <p>Results</p> <p>In 12 patients tested on a single occasion NIV increased T<sub>lim </sub>from 184(65) seconds to 331(229) seconds (p = 0.04) and patients desaturated less (median difference = 3.5%, p = 0.029). In the second study, 60 patients were admitted to hospital during a three month period of whom only 18(30)% were eligible to participate and of these patients, only four (7%) consented to participate.</p> <p>Conclusion</p> <p>NIV improves exercise tolerance in patients with acute exacerbations of chronic respiratory disease but the applicability of this approach in routine clinical practice may be limited.</p> <p>Trial registration</p> <p><url>http://www.controlled-trials.com/ISRCTN35692743</url></p

    The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial protocol

    Get PDF
    Background: People with lung cancer have substantial symptom burden and more unmet needs than the general cancer population. Physical activity (PA) has been shown to positively influence quality of life (QOL), fatigue and daily functioning in the curative treatment of people with breast and colorectal cancers and lung diseases, as well as in palliative settings. A randomised controlled trial (RCT) is needed to determine if lung cancer patients benefit from structured PA intervention. The Physical Activity in Lung Cancer (PAL) trial is designed to evaluate the impact of a 2-month PA intervention on fatigue and QOL in patients with non-resectable lung cancer. Biological mechanisms will also be studied.Methods/design: A multi-centre RCT with patients randomised to usual care or a 2-month PA programme, involving supervised PA sessions including a behavioural change component and home-based PA. QOL questionnaires, disease and functional status and body composition will be assessed at baseline, 2, 4 and 6 months follow-up. The primary endpoint is comparative levels of fatigue between the 2 arms. Secondary endpoints include: QOL, functional abilities and physical function. Exploratory endpoints include: anxiety, depression, distress, dyspnoea, PA behaviour, fitness, hospitalisations, survival, cytokines and insulin-like growth factor levels.Discussion: This study will provide high-level evidence of the effect of PA programmes on cancer-related fatigue and QOL in patients with advanced lung cancer. If positive, the study has the potential to change care for people with cancer using a simple, inexpensive intervention to improve their QOL and help them maintain independent function for as long as possible.Trial registration: Australian New Zealand Clinical Trials Registry No. ACTRN12609000971235. © 2012 Dhillon et al.; licensee BioMed Central Ltd
    corecore